Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
Recruiting · NCT06699394 · Registry updated 2025-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, proteostasis deficiencies | Recruiting | Not applicable | 2025-04-24 | NCT06699394 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University People's Hospital | 269 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fuxing Hospital affiliated to Capital Medical University | Beijing | China | 1 |
| Peking University Peoples Hospital | Beijing | China | 8 |